Stock · CAH · Healthcare
United States · Large Cap · listed since 1987 · Revenue 12 mo. $254.2B
Price as of 11/06/2026
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Original text from the data provider
Summary
57.8 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €4.1B (2026), it supports €45.1B. The remaining €10.1B of the market value assume it grows 2.9% a year for 10 years and not at all afterwards.
Required FCF growth per year
2.9%
no growth afterwards
Price to operating cash flow 12.4×, above its usual range.
Middle half of 20 quarters: 6.4× to 11.0×, median 9.0×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
7 more unchanged: Revenue, 12 mo., FCF, 12 mo., Gross margin, EBIT margin, FCF margin, Net debt, Shares outstanding
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | −55.72% | 11.52% | Rank 5 |
| Return on capital (Greenblatt) | 64.97% | 32.55% | Rank 79 |
| EBIT margin | 1.03% | 18.31% | Rank 6 |
| FCF margin | 1.78% | 14.12% | Rank 11 |
| Gross margin | 3.84% | 60.99% | Rank 2 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 14.23% | 8.04% | Rank 80 |
| Earnings growth, 3 years per year | 79.07% | 5.44% | Rank 95 |
| Earnings growth, 5 years per year | 28.33% | 7.00% | Rank 91 |
| Sustainable growth (ROE × retained earnings) | 0.26% | 3.66% | Rank 6 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 2.66% | 2.90% | Rank 43 |
| FCF yield | 7.35% | 3.63% | Rank 88 |
| EV/saleslower is better | 0.26 | 4.03 | Rank 96 |
| EV/EBITlower is better | 25.50 | 21.73 | Rank 40 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 27.63% | 8.66% | Rank 77 |
| Share price, 6 months | 48.44% | 24.27% | Rank 85 |
| Share price, 3 months | 20.07% | 15.42% | Rank 66 |
| Distance from 52-week high | 0.00% | −7.35% | Rank 96 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −1.59% | 0.30% | Rank 68 |
| Change in share countlower is better | −2.07% | 0.00% | Rank 79 |
| Dividend streak in years | 2 | 10 | Rank 36 |
| Price reaction to results, market-adjusted | 6.21% | 0.05% | Rank 88 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | −5.03% | 48.40% | Rank 1 |
| Net debt/EBITDAlower is better | 1.46 | 1.11 | Rank 42 |
| Debt to equitylower is betterdoes not count towards the rank | −3.15 | 0.48 | |
| Volatility, 1 yearlower is better | 25.90% | 31.42% | Rank 85 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF | Shares | Net debt |
|---|---|---|---|---|---|
| 2017 | 130.0 | 1.6% | $797.0M | 320M | $3.5B |
| 2018 | 136.8 | 0.1% | $2.4B | 315M | $7.3B |
| 2019 | 145.5 | 1.4% | $2.4B | 301M | $5.5B |
| 2020 | 152.9 | −2.7% | $1.6B | 293M | $4.0B |
| 2021 | 162.5 | 0.3% | $2.0B | 294M | $3.3B |
| 2022 | 181.3 | −0.3% | $2.7B | 279M | $1.1B |
| 2023 | 205.0 | 0.4% | $2.4B | 262M | $1.1B |
| 2024 | 226.8 | 0.6% | $3.3B | 247M | $476.0M |
| 2025 | 222.6 | 1.0% | $1.9B | 242M | $5.5B |
| 2026 | 254.2 | 1.0% | $4.5B | 237M | $5.1B |
4 of 7 StockScorer Score rules met · How the score is built
Cardinal Health Inc mainly meets criteria in the Valuation category. Result from 18 strategies checked.
Cardinal Health Inc is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
4 of 7 rules met
6 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Cardinal Health Inc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 37.6 | 30.0 |
| P/B ratio | −19.3 | 4.8 |
| Return on equity (ROE) | −55.7% | 11.5% |
| Equity ratio | −5.0% | 48.4% |
| Debt-to-equity (D/E) | −3.15 | 0.48 |
| Dividend yield | 0.8% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| CAH | Cardinal Health Incthis page | |
| COR | Cencora Inc. | Low4.5 |
| MCK | McKesson Corporation | Low4.5 |
| SIG.AX | Sigma Healthcare Ltd | locked |
| HSIC | Henry Schein Inc | locked |
| M12.DE | M1 Kliniken AG | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.